Sunday , April 13 2025
Home / Lars P. Syll / Le vaccin d’AstraZeneca et la balance bénéfice-risque

Le vaccin d’AstraZeneca et la balance bénéfice-risque

Summary:
Le vaccin d’AstraZeneca et la balance bénéfice-risque .[embedded content]

Topics:
Lars Pålsson Syll considers the following as important:

This could be interesting, too:

Lars Pålsson Syll writes Schuldenbremse bye bye

Lars Pålsson Syll writes Vad historien lär oss

Lars Pålsson Syll writes Krigskeynesianismens återkomst

Lars Pålsson Syll writes From one old guy to another old guy

Le vaccin d’AstraZeneca et la balance bénéfice-risque

.

Lars Pålsson Syll
Professor at Malmö University. Primary research interest - the philosophy, history and methodology of economics.

Leave a Reply

Your email address will not be published. Required fields are marked *